Relationship Obsessive Beliefs and Thought Control

March 28, 2023 updated by: Meltem puşuroğlu, Recep Tayyip Erdogan University Training and Research Hospital

Corresponding Author

Obsessive beliefs and thought control have been mostly investigated in obsessive-compulsive disorder in the literature. However, there is an increasing body of literature indicating that obsessive beliefs and thought control also play a role in the development of other anxiety disorders. In the study, investigators hypothesised that obsessive beliefs and thought control are effective in generalised anxiety disorder and panic disorder and increase anxiety symptoms and aimed to investigate the accuracy of this hypothesis.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Active, not recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

Obsessive beliefs are considered as a compulsive thought system in the cognitive model of obsessive-compulsive disorder. Obsessive beliefs are analysed under six main headings. These are control of thoughts, intolerance of uncertainty, exaggerated perception of responsibility, overemphasis of thoughts, exaggerated perception of threat and perfectionism. Although it is thought to play a role in the development of obsessions, it can sometimes be seen independent of obsessions . This dysfunctional distorted thought system sometimes turns into unnecessary threat perception and may pave the way for mental illnesses in the individual. When these distorted cognitive thoughts come to the mind, the person has an excessive mental effort to control the thoughts. As much as the thoughts cause distress, the endeavour to control the thoughts may cause mental distress in the person. Although all of these dysfunctional thoughts are associated with an obsession, the effect of thought control and obsessive beliefs on other mental illnesses has recently been investigated. In particular, perfectionism and increased threat perception have been associated with anxiety disorders as well as obsessions . Obsessive beliefs have often been associated with obsessive-compulsive disorder. However, there are similarities in the cognitive schemas of obsessive-compulsive disorder and anxiety disorders. Anxiety disorders are characterised by a vague state of anxiety and accompanying physical symptoms. Patients with anxiety disorders may be hypersensitive to some feelings and thoughts. Anxiety attacks may be triggered by exaggerated threat perception in obsessive beliefs. In addition, intolerance of uncertainty is also associated with anxiety disorders. Cognitive distortions have a role in the development of both obsessive-compulsive disorder and anxiety disorders . Obsessive beliefs and thought control have been mostly associated with obsessive-compulsive disorder in the literature. However, it has recently been thought that these dysfunctional compulsive thoughts and the distress experienced to control these thoughts are the cognitive basis of all anxiety disorders. Information on this subject is limited in the literature. Our study aims to contribute to the literature on this subject.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Rize, Turkey, 53200
        • RTE University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

with panic disorder patient and generalized anxiety disorder patient

Description

Inclusion Criteria:

  • with panic disorder patient and generalized anxiety disorder
  • no other psychiatric illness such as alzheimer, mental retardation, parkinson disease
  • had academic capacity for filling the scales
  • no taking any drugs
  • being age 18-65
  • giving consent to be involved in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
The study will include healthy controls, patients with panic disorder and patients with anxiety disorder. 3 groups will be formed and obsessive beliefs scale and thought control scale will be applied to the groups.
Time Frame: 3 months
Obsessive beliefs and will be applied in patients with panic disorder and anxiety disorder. scale results will be evaluated statistically. the hypothesis of the study is that obsessive beliefs scale scores will be higher in the patient group. The mentioned scales are the scales used for diagnosis in psychiatry. the answers have a score and a numerical value is obtained by adding the scores. the lowest score that can be obtained from the obsessive beliefs scale is 44 and the highest score is 208. higher scores on the scale are negative and mean more obsessive beliefs
3 months
The study will include healthy controls, patients with panic disorder and patients with anxiety disorder. 3 groups will be formed and obsessive beliefs scale and thought control scale will be applied to the groups.
Time Frame: 3 months
thought control scale will be applied in patients with panic disorder and anxiety disorder. scale results will be evaluated statistically. the hypothesis of the study is that thought control scale scores will be higher in the patient group. The mentioned scales are the scales used for diagnosis in psychiatry. the answers have a score and a numerical value is obtained by adding the scores.. the lowest score that can be obtained from the thought control scale is 30 and the highest is 120. increasing scores were evaluated negatively. it is associated with more difficult thought control.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Recep Tayyip Erdogan University Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 1, 2022

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 1, 2023

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 20, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 30, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 28, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 30, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 30, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 28, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • RTEuniversity

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings